Rafferty Asset Management
ROIV icon

Rafferty Asset Management’s Roivant Sciences ROIV Stock Holding History

Rafferty Asset Management’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.69M Sell
104,268
-54,568
-34% -$1.61M 0.01% 445
2026
Q1 		$4.4M Sell
158,836
-135,947
-46% -$3.49M 0.02% 429
2025
Q4 		$6.4M Sell
294,783
-181,090
-38% -$3.57M 0.02% 351
2025
Q3 		$7.2M Sell
475,873
-122,358
-20% -$1.51M 0.02% 353
2025
Q2 		$6.74M Buy
598,231
+95,280
+19% +$1.03M 0.02% 342
2025
Q1 		$5.07M Sell
502,951
-219,478
-30% -$2.37M 0.02% 367
2024
Q4 		$8.55M Buy
722,429
+55,960
+8% +$662K 0.03% 311
2024
Q3 		$7.69M Sell
666,469
-211,240
-24% -$2.41M 0.03% 326
2024
Q2 		$9.28M Sell
877,709
-34,484
-4% -$378K 0.03% 296
2024
Q1 		$9.61M Sell
912,193
-60,941
-6% -$657K 0.04% 275
2023
Q4 		$10.9M Buy
973,134
+195,136
+25% +$1.9M 0.05% 252
2023
Q3 		$9.09M Sell
777,998
-14,633
-2% -$165K 0.05% 248
2023
Q2 		$7.99M Sell
792,631
-56,075
-7% -$502K 0.05% 281
2023
Q1 		$6.26M Buy
848,706
+482,095
+132% +$3.97M 0.04% 331
2022
Q4 		$2.93M Buy
366,611
+218,279
+147% +$1.21M 0.02% 490
2022
Q3 		$478K Buy
148,332
+118,094
+391% +$457K 0.01% 864
2022
Q2 		$123K Buy
+30,238
New +$120K ﹤0.01% 1061

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Rafferty Asset Management's ROIV Position: Q2 2026 in Review

Rafferty Asset Management reduced its Roivant Sciences (ROIV) stake by 34% in Q2 2026, selling an estimated $1.61M and leaving 104,268 shares worth $3.69M. The position accounts for 0.01% of the portfolio, ranked #445.

Rafferty Asset Management first reported a position in ROIV in Q2 2022 and has held it in 17 quarters since. The position peaked at $10.9M in Q4 2023. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Rafferty Asset Management held 104,268 shares of Roivant Sciences worth $3.69M as of Q2 2026.
  • Rafferty Asset Management sold 54,568 Roivant Sciences shares in Q2 2026, an estimated $1.61M.
  • Roivant Sciences made up 0.01% of Rafferty Asset Management's portfolio in Q2 2026, its #445 holding.
  • Rafferty Asset Management first reported a position in Roivant Sciences in Q2 2022 and has held it in 17 quarters since.
  • Rafferty Asset Management's Roivant Sciences position peaked at $10.9M in Q4 2023.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Rafferty Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.